Cancer suicide gene therapy: a patent review.


INTRODUCTION Cancer is considered the second leading cause of death worldwide despite the progress made in early detection and advances in classical therapies. Advancing in the fight against cancer requires the development of novel strategies, and the suicide gene transfer to tumor cells is providing new possibilities for cancer therapy. AREAS COVERED In… (More)
DOI: 10.1080/13543776.2016.1211640

Cite this paper

@article{Navarro2016CancerSG, title={Cancer suicide gene therapy: a patent review.}, author={Sa{\'u}l Abenhamar Navarro and Esmeralda Carrillo and Carmen Gri{\~n}{\'a}n-Lis{\'o}n and Ana Mart{\'i}n and Macarena Per{\'a}n and Juan Antonio Marchal and Houria Boulaiz}, journal={Expert opinion on therapeutic patents}, year={2016}, volume={26 9}, pages={1095-104} }